Allergan Investors Lose Class Cert. Bid Over 'Serial Litigant'
Allergan investors lost a bid to pursue a stock-drop suit as a class action against the pharmaceutical company, with a New York federal judge ruling Tuesday that the proposed lead plaintiff,...To view the full article, register now.
Already a subscriber? Click here to view full article